Ghent University Academic Bibliography

Your filters: cql: author="Aftimos, P" or (type any "bookEditor issueEditor" and editor="Aftimos, P")

Add to list
ROSALINE : a phase II, neoadjuvant study targeting ROS1 in combination with endocrine therapy in invasive lobular carcinoma of the breast

E Agostinetto, G Nader-Marta, M Paesmans, L Ameye, I Veys, L Buisseret, P Neven, D Taylor, C Fontaine, FP Duhoux, et al.

(2022) FUTURE ONCOLOGY. 18(22). p.2381-2392
Add to list
Molecular test algorithms for breast tumours

A Hébrant, K Punie, FP Duhoux, C Colpaert, G Floris, K Lambein, P Neven, M Berlière, R Salgado, M Chintinne, et al.

(2019) BELGIAN JOURNAL OF MEDICAL ONCOLOGY. 13(2). p.40-45
Add to list
- Conference Paper
- C3
A phase I global trial targeting multiple solid and hematologic malignancies through a NKG2D receptor-based CAR-T immunotherapy

B Verma, A Awada, P Aftimos, P Lewalle, N Meuleman, J-P Machiels, G Catala, E Vandenneste, J Brayer, D Sallman, et al.

(2017) ANNALS OF ONCOLOGY. 28(suppl. 5).
Add to list
- Conference Paper
- C3
A phase I study in T cell lymphoma patients treated with anti-CD70 simple antibody (TM) ARGX-110

JM Michot, M Maerevoet, P Aftimos, Sylvie Rottey (UGent) , C Rolfo, Fritz Offner (UGent) , L Van Rompaey, M Moshir, H de Haard, K Silence, et al.

(2016) HAEMATOLOGICA. 101(suppl. 1). p.396-396
Add to list
- Conference Paper
- C3
A phase I study in T cell lymphoma patients treated with anti-CD70 simple antibody T ARGX-110

JM Michot, K Silence, M Maerevoet, P Aftimos, S Rottey, C Rolfo, Fritz Offner (UGent) , L Van Rompaey, M Moshir, H de Haard, et al.

(2016) HAEMATOLOGICA. 101(suppl. 1). p.105-105

Academic Bibliography

ROSALINE : a phase II, neoadjuvant study targeting ROS1 in combination with endocrine therapy in invasive lobular carcinoma of the breast

Molecular test algorithms for breast tumours

A phase I global trial targeting multiple solid and hematologic malignancies through a NKG2D receptor-based CAR-T immunotherapy

A phase I study in T cell lymphoma patients treated with anti-CD70 simple antibody (TM) ARGX-110

A phase I study in T cell lymphoma patients treated with anti-CD70 simple antibody T ARGX-110

Contents

Support

Contact